Search

everythinglearnresearchcommunity

for

Search:↓

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

A rare pigmented skin tumor called melanotrichoblastoma was diagnosed in a 51-year-old woman.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

Exclamation-mark hairs and yellow dots indicate alopecia areata, while follicular ostia loss and white scarring indicate lichen planopilaris and discoid lupus erythematosus.

Consider systemic lupus erythematosus in patients with unexplained intracranial hypertension.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

Iron deficiency causes many symptoms, and transferrin saturation is a better diagnostic marker than hemoglobin.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.

A 13-year-old boy had flu-like symptoms and low platelets after a camping trip, with a confirmed diagnosis later.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Erdr1 could be a new marker for diagnosing hair loss.

Higher oxidative stress markers are linked to hair loss in post-COVID-19 patients.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.